Assert-IQ vs HealthCCSng
AI Verdict
Choose Assert-IQ if…
Choose Assert-IQ if your primary need is long-term, continuous monitoring for patients with suspected, often intermittent, heart rhythm disorders that may not be captured by shorter-term diagnostic methods. This tool is ideal for diagnosing elusive arrhythmias over several years and enabling remote management with proactive alerts and patient symptom logging.
View Assert-IQ →Choose HealthCCSng if…
Choose HealthCCSng if you aim to leverage existing routine CT scans to proactively identify patients at risk of coronary artery disease by automatically detecting and quantifying coronary artery calcification. This solution is best suited for integrating seamlessly into radiology workflows to provide automated, objective cardiovascular risk stratification without requiring dedicated cardiac imaging.
View HealthCCSng →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Assert-IQ | HealthCCSng |
|---|---|---|
| Pricing | Enterprise | Not publicly available |
| Deployment | Hybrid | Cloud-based, integrates with PACS and EMR systems |
| FDA Status | Cleared AI-estimated | Yes AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
HealthCCSngHealthCCSng integrates seamlessly into existing radiology workflows by analyzing routine CT scans without requiring special protocols or patient activators. Its automated workflow delivers results directly to PACS and EMR systems, minimizing additional steps for clinicians. Assert-IQ, while offering remote monitoring, still involves a minimally invasive insertion and patient interaction with an activator.
Clinical Value
Assert-IQAssert-IQ provides continuous, long-term cardiac monitoring for up to six years, offering advanced arrhythmia detection and proactive alerts crucial for diagnosing and managing complex heart rhythm disorders. This direct, ongoing diagnostic and management support for a dynamic condition offers a profound and sustained impact on patient care. HealthCCSng, while valuable for risk stratification, provides a snapshot assessment of CAD risk from existing scans.
Pricing & Value
TieBoth Assert-IQ and HealthCCSng lack public pricing information, requiring direct contact with the respective vendors for institutional details. Without any transparent pricing or free trial options, it is impossible to conduct a meaningful comparison of their cost-effectiveness or overall value proposition. Therefore, a definitive winner cannot be determined in this dimension.
Enterprise Readiness
Assert-IQAssert-IQ benefits from being developed by Abbott Medical, a globally recognized and long-established medical device company, which inherently provides robust enterprise-level support, regulatory experience, and a trusted brand. While HealthCCSng offers strong integration with PACS and EMR systems, Abbott's extensive infrastructure and history provide a higher degree of assurance for large-scale deployments and long-term operational stability.
Innovation
HealthCCSngHealthCCSng demonstrates significant innovation by leveraging AI to extract critical coronary artery calcification data from routine, non-gated CT scans already performed for other indications. This ability to repurpose existing imaging data to provide novel cardiac risk assessment without additional procedures or specialized scans is a highly efficient and impactful application of AI. Assert-IQ's extended monitoring duration and remote capabilities are advancements, but HealthCCSng's approach to data utilization is more disruptive.
Support & Docs
Assert-IQGiven Abbott Medical's extensive history, global presence, and established reputation as a leading medical device manufacturer, Assert-IQ is likely backed by a comprehensive and mature support infrastructure, including technical assistance, field service, and extensive documentation. In contrast, Nano-X AI, while a specialized AI vendor, does not provide specific details on its support offerings, making it reasonable to infer that Abbott's established network would be more robust.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Assert-IQ | HealthCCSng |
|---|---|---|
| Name | Assert-IQ | HealthCCSng |
| Company | Abbott Medical | Nano-X AI |
| Primary Function | Long-term, continuous monitoring and advanced arrhythmia detection to aid physicians in diagnosing and managing patients with suspected heart rhythm disorders. | Analyzes routine CT scans to automatically detect and quantify coronary artery calcification (CAC), identifying patients at risk of coronary artery disease. |
| Tagline | Advanced, long-term insertable cardiac monitoring for comprehensive arrhythmia detection. | Empowering physicians in the assessment of coronary artery calcium from routine CT scans. |
| Categories | Cardiology AI, Clinical Decision Support & Reference | Cardiology AI |
| Key Detection/Analysis | Long-term continuous cardiac monitoring (up to 6 years), Advanced arrhythmia detection algorithms, Remote monitoring capabilities, Patient activator for symptom logging. | Analyzes non-contrast, non-ECG gated chest CT scans, Automatically detects and quantifies coronary artery calcification (CAC), Categorizes studies into 'zero', 'low', 'moderate', and 'severe' CAC categories, Generates a numerical calcium score, Provides visualization of calcified plaques. |
Videos
Demos, reviews, and walkthroughs featuring Assert-IQ and HealthCCSng.